Related Experiment Video
Updated: Sep 18, 2025

RhoC GTPase Activation Assay
Published on: August 22, 2010
RhoA functionally collaborates with HSPA1A to promote the migratory phenotype of cancer cells
Sumaiya Nabi1, Mohammad Amin Hajam1, Umar Mushtaq2
1Department of Biochemistry, University of Kashmir, Hazratbal, Srinagar 190006, Jammu and Kashmir, India.
Abstract:
RhoA, a member of the GTPase family, plays a pivotal role in attaining a migratory phenotype, mainly by regulating cytoskeleton dynamics, cell adhesion and membrane protrusions. Although many upstream regulators and downstream effectors of RhoA have been identified, the discovery of new interacting partners continues to expand its interactome, providing fresh insights into its regulation and function. Co-immunoprecipitation and fluorescence microscopy were used to study the interaction, localization and morphological effects of HSPA1A and RhoA. The interaction was validated by modulating the protein expression through transfections and silencing approaches. Cell proliferation, migration and viability were assessed using MTT, a Boyden chamber and FACS assays, respectively. Our study identified HSPA1A, as an unexplored interacting partner of RhoA under physiological conditions. Functional analyses showed that the interaction between HSPA1A and RhoA enhances the migratory potential of cancer cells, induces G0/G1 cell cycle arrest and promotes a rounded cell morphology. Under HSPA1A transfection, increased RhoA protein levels were observed, while the silencing of HSPA1A resulted in decreased RhoA levels. This study highlights the critical role of HSPA1A-RhoA interaction in regulating cancer cell migration, morphology and cell cycle progression. These findings lay the groundwork for future research into its potential clinical applications.
Insights
Heat shock protein HSPA1A interacts with RhoA, enhancing cancer cell migration and altering cell morphology. This discovery reveals a new regulatory pathway impacting cancer progression and potential therapeutic targets.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- RhoA is a GTPase crucial for cell migration, cytoskeleton dynamics, and adhesion.
- Understanding RhoA's interactome is key to uncovering new regulatory mechanisms and functions.
- Previous research has identified several RhoA regulators, but novel partners are continually being discovered.
Purpose of the Study:
- To identify and characterize novel interacting partners of RhoA.
- To investigate the functional consequences of the interaction between HSPA1A and RhoA in cancer cells.
- To explore the role of HSPA1A-RhoA interaction in cancer cell migration, morphology, and cell cycle.
Main Methods:
- Co-immunoprecipitation and fluorescence microscopy to study HSPA1A-RhoA interaction and localization.
- Transfection and silencing approaches to modulate protein expression and validate interactions.
- MTT, Boyden chamber, and FACS assays to assess cell proliferation, migration, and viability.
Main Results:
- HSPA1A was identified as a novel interacting partner of RhoA under physiological conditions.
- The HSPA1A-RhoA interaction enhances cancer cell migratory potential.
- This interaction induces G0/G1 cell cycle arrest and promotes a rounded cell morphology.
- HSPA1A modulation directly affects RhoA protein levels, with transfection increasing and silencing decreasing RhoA.
Conclusions:
- HSPA1A is a novel interacting partner of RhoA with significant implications for cancer biology.
- The HSPA1A-RhoA interaction critically regulates cancer cell migration, morphology, and cell cycle progression.
- This interaction presents a potential target for future clinical applications in cancer therapy.
Related Concept Videos
Cell Polarization by Rho Proteins
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Ras Gene
Ras is a...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

